PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Endocyte Announces Fourth Quarter and Full Year 2016 Earnings Conference Call
WEST LAFAYETTE, Ind. , March 02, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. , (NASDAQ:ECYT) announced today that the company will host a conference call on Friday, March 10th , at 8:30 a.m. EST to discuss its fourth quarter and full year financial results and provide an operational update.
View HTML
Toggle Summary Endocyte to Present at the Cowen and Company 37th Annual Health Care Conference
WEST LAFAYETTE, Ind. , March 01, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company's management team will present at the Cowen and
View HTML
Toggle Summary Endocyte Appoints Michael T. Andriole as Chief Financial Officer
WEST LAFAYETTE, Ind. , Feb. 21, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that Michael T. Andriole has been appointed as chief financial
View HTML
Toggle Summary Endocyte to Present at the IASLC 17th World Conference on Lung Cancer
WEST LAFAYETTE, Ind. , Dec. 01, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that data from ongoing phase 1 trials of Endocyte's SMDC EC1456 will
View HTML
Toggle Summary Endocyte Reports Third Quarter 2016 Financial Results
- Confirmed Maximum Dose for EC1169 and Initiated Expansion Phase in Prostate Cancer Patients - - First Confirmed RECIST Partial Response Observed in EC1169 Dose Escalation Reported at European Society for Medical Oncology (ESMO) in October - - Conference Call Today at 4:30 p.m.
View HTML
Toggle Summary Endocyte Announces Third Quarter 2016 Earnings Conference Call
WEST LAFAYETTE, Ind. , Nov. 02, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. , (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, Nov. 9th , at 4:30 p.m. EST to discuss its third quarter financial results and provide an operational update.
View HTML
Toggle Summary Endocyte to Present at the 25th Annual Credit Suisse Healthcare Conference
WEST LAFAYETTE, Ind. , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy today announced that the company's management team will present at the 25 th Annual
View HTML
Toggle Summary Endocyte Presents Data on Two Lead Clinical Programs at European Society for Medical Oncology (ESMO) 2016 Congress
Anti-tumor activity demonstrated in dose escalation trials for EC1456 and EC1169
View HTML
Toggle Summary Endocyte Announces Presentations at the European Society for Medical Oncology (ESMO)
WEST LAFAYETTE, Ind. , Sept. 29, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that two posters will be presented at the European Society for
View HTML
Toggle Summary Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference
WEST LAFAYETTE, Ind. , Sept. 20, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company's management team will present at the Ladenburg
View HTML